These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18154136)

  • 21. Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study.
    Kelishadi R; Cook SR; Motlagh ME; Gouya MM; Ardalan G; Motaghian M; Majdzadeh R; Ramezani MA
    J Am Diet Assoc; 2008 Jan; 108(1):82-90. PubMed ID: 18155992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile.
    Choi HK; De Vera MA; Krishnan E
    Rheumatology (Oxford); 2008 Oct; 47(10):1567-70. PubMed ID: 18710901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the concept of 'cardiometabolic risk' more useful than 'metabolic syndrome'?
    Koshiyama H; Taniguchi A; Inagaki N; Seino Y
    Diabet Med; 2007 May; 24(5):571. PubMed ID: 17470194
    [No Abstract]   [Full Text] [Related]  

  • 25. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome: diabetes and cardiovascular disease.
    Gupta S; Gupta BM
    Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic syndrome: how to approach differing definitions.
    Pi-Sunyer X
    Med Clin North Am; 2007 Nov; 91(6):1025-40, vii. PubMed ID: 17964907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why metabolic syndrome criteria have not made prime time: a view from the clinic.
    Sattar N
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S30-4. PubMed ID: 18469837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metabolic syndrome: protective obesity].
    Nau JY
    Rev Med Suisse; 2010 Mar; 6(241):644-5. PubMed ID: 20408371
    [No Abstract]   [Full Text] [Related]  

  • 30. What do cancer, diabetes, and cardiovascular disease have in common?
    Van Horn L
    J Am Diet Assoc; 2009 Aug; 109(8):1329. PubMed ID: 19631034
    [No Abstract]   [Full Text] [Related]  

  • 31. Recognition and implications of the metabolic syndrome.
    Rizvi AA
    J S C Med Assoc; 2004 Apr; 100(4):107-12. PubMed ID: 15162668
    [No Abstract]   [Full Text] [Related]  

  • 32. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome and the menopause.
    Kaaja RJ
    Menopause Int; 2008 Mar; 14(1):21-5. PubMed ID: 18380957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
    Song SH; Hardisty CA
    QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metabolic syndrome, definitions and physiopathology].
    Monnier L; Bénichou M
    Soins; 2004 Apr; (684 Pt 2):4-7. PubMed ID: 15151084
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome: a child is not a small adult.
    Pietrobelli A; Malavolti M; Battistini NC; Fuiano N
    Int J Pediatr Obes; 2008; 3 Suppl 1():67-71. PubMed ID: 18278635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
    Steiner G
    Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic syndrome and cardiovascular risk factors in the menopausal transition.
    Siseles N; Berg G
    Gynecol Endocrinol; 2010 Jan; 26(1):1-3. PubMed ID: 19598036
    [No Abstract]   [Full Text] [Related]  

  • 40. Psoriasis as the marker of underlying systemic disease.
    Kourosh AS; Miner A; Menter A
    Skin Therapy Lett; 2008 Feb; 13(1):1-5. PubMed ID: 18357363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.